190 related articles for article (PubMed ID: 23349314)
1. Molecular photoacoustic imaging of follicular thyroid carcinoma.
Levi J; Kothapalli SR; Bohndiek S; Yoon JK; Dragulescu-Andrasi A; Nielsen C; Tisma A; Bodapati S; Gowrishankar G; Yan X; Chan C; Starcevic D; Gambhir SS
Clin Cancer Res; 2013 Mar; 19(6):1494-502. PubMed ID: 23349314
[TBL] [Abstract][Full Text] [Related]
2. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of integrin β6 as a tumor recurrence factor in follicular thyroid carcinoma.
Zhuang ZN; Xu ZJ; Zhou Q; Xu XZ; Tian J; Liu YF; Guo S; Wang JY; Xu KS
Head Neck; 2015 Oct; 37(10):1439-47. PubMed ID: 24844802
[TBL] [Abstract][Full Text] [Related]
4. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and imaging of an activatable photoacoustic probe.
Levi J; Kothapalli SR; Ma TJ; Hartman K; Khuri-Yakub BT; Gambhir SS
J Am Chem Soc; 2010 Aug; 132(32):11264-9. PubMed ID: 20698693
[TBL] [Abstract][Full Text] [Related]
6. MMP-2-Activatable Photoacoustic Tumor Imaging Probes Based on Al- and Si-Naphthalocyanines.
Miki K; Imaizumi N; Nogita K; Oe M; Mu H; Huo W; Harada H; Ohe K
Bioconjug Chem; 2021 Aug; 32(8):1773-1781. PubMed ID: 34167292
[TBL] [Abstract][Full Text] [Related]
7. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.
Bremer C; Bredow S; Mahmood U; Weissleder R; Tung CH
Radiology; 2001 Nov; 221(2):523-9. PubMed ID: 11687699
[TBL] [Abstract][Full Text] [Related]
8. An Activatable Cancer-Targeted Hydrogen Peroxide Probe for Photoacoustic and Fluorescence Imaging.
Weber J; Bollepalli L; Belenguer AM; Antonio MD; De Mitri N; Joseph J; Balasubramanian S; Hunter CA; Bohndiek SE
Cancer Res; 2019 Oct; 79(20):5407-5417. PubMed ID: 31455691
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-initiated aggregation of melanin nanoparticles as highly efficient contrast agent for enhanced tumor accumulation and dual-modal imaging.
Meng T; Fan B; Li Q; Peng X; Xu J; Zhang R
J Mater Chem B; 2020 Nov; 8(43):9888-9898. PubMed ID: 33034320
[TBL] [Abstract][Full Text] [Related]
10. Aluminum naphthalocyanine conjugate as an MMP-2-activatable photoacoustic probe for in vivo tumor imaging.
Miki K; Imaizumi N; Nogita K; Oe M; Mu H; Huo W; Ohe K
Methods Enzymol; 2021; 657():89-109. PubMed ID: 34353500
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Yeh MW; Rougier JP; Park JW; Duh QY; Wong M; Werb Z; Clark OH
Endocr Relat Cancer; 2006 Dec; 13(4):1173-83. PubMed ID: 17158762
[TBL] [Abstract][Full Text] [Related]
12. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
Sanii S; Saffar H; Tabriz HM; Qorbani M; Haghpanah V; Tavangar SM
Asian Pac J Cancer Prev; 2012; 13(5):2175-8. PubMed ID: 22901190
[TBL] [Abstract][Full Text] [Related]
14. Multispectral Photoacoustic Imaging of Tumor Protease Activity with a Gold Nanocage-Based Activatable Probe.
Liu C; Li S; Gu Y; Xiong H; Wong WT; Sun L
Mol Imaging Biol; 2018 Dec; 20(6):919-929. PubMed ID: 29736563
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
17. MMP-2/9-Specific Activatable Lifetime Imaging Agent.
Rood MT; Raspe M; ten Hove JB; Jalink K; Velders AH; van Leeuwen FW
Sensors (Basel); 2015 May; 15(5):11076-91. PubMed ID: 25985157
[TBL] [Abstract][Full Text] [Related]
18. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.
Waschkau B; Faust A; Schäfers M; Bremer C
Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387
[TBL] [Abstract][Full Text] [Related]
19. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
[TBL] [Abstract][Full Text] [Related]
20. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
